Biochemistry Meets Mass Production: Scalable Reagent Solutions for PCR Applications

Imagine you’re developing a new diagnostic test for a deadly virus that spreads rapidly. The test requires reagents for polymerase chain reaction (PCR), which amplify small quantities of DNA into a detectable amount. However, traditional methods of producing these reagents aren’t suitable for the scale required to produce the diagnostic tests on a mass level, and the reagents cannot be stored at room temperature.

This presents a significant challenge for the production and distribution of the diagnostic tests, as well as their shelf life. Fortunately, advancements in lyophilization techniques have made it possible to produce PCR reagents in a scalable and efficient manner.

How Lyophilization Enables PCR Applications

Lyophilization is a process that removes water from a substance by freezing it and then sublimating the ice—simply put, freeze drying. This enables materials to be kept in a well-preserved and shelf-stable form.

Lyophilization has revolutionized the storage of reagents used in PCR and point-of-care testing (POCT) devices. The benefits of lyophilization are significant as it enables the storage, utilization, and transportation of the material without the need for freezers, simplifying the entire process.

Lyophilization is also available in different forms, including lyobeads/microspheres, powder, and disc. The different forms of lyophilized reagents significantly impact the ease of dispensation, device complexity, scalability, ease of reagent onboarding, and overall yield.

Why Lyobeads Fall Short in Manufacturing

Lyobeads are commonly used for lyophilizing PCR reagents, but they do have limitations in manufacturing. Lyobeads are breakable and can escape reagent onboarding via static electricity. The handling of lyobeads can cause manufacturing bottlenecks that prevent efficient high yields. Lyobeads are not automation or robot-friendly and require expensive equipment investment.

Recipe restrictions come into play due to the above limitations, requiring minimum mass or more “sugar coating” with excipients to prevent breaking.

Furthermore, consistent lyophilization of reagents is challenging: it increases prices and reduces yield and efficiency. Finally, agitation is required during rehydration for reagent usage in order to prevent air bubbles from interfering with reaction or detection.

The Plastic Mesh Pod: Improving Speed-to-Market and Scalability in Mass Production

The plastic mesh pod is a new and innovative solution to the limitations of lyobeads for lyophilizing reagents used in PCR applications. Lyobeads are breakable, prone to manufacturing bottlenecks, and not automation friendly. On the other hand, plastic mesh pods offer several benefits, including:

Efficient Handling

Plastic mesh pods offer an easy and efficient handling solution for lyophilized reagents used in PCR applications. The pod is made from bio-compatible plastic material with a unique mesh bottom that allows for the easy handling, storage, and dispensation of reagents. Unlike lyobeads, which can escape reagent onboarding via static electricity, lyophilized reagents encased in plastic mesh pods can be easily assembled to PCR cartridges or microfluidic devices. This ease in reagent onboarding reduces waste from lost or broken reagents and improves overall production yield.

Scalability in Mass Production

The plastic mesh pod is designed for scalability in mass production. The pod enables higher production yields from robot automation without the need for expensive equipment specialized in handling lyobeads. The plastic mesh pod alleviates the errors associated with bead lyophilization and the need for liquid nitrogen, trays, and recipe restrictions. Lyophilized reagents in the plastic pod make production ramp up faster than lyobeads, as assembly automation of plastic pods are less complex and less costly than automating control of lyobeads.

Improved Speed-to-Market

The plastic mesh pod is an excellent solution for improving speed-to-market in PCR applications. The pod is designed to reduce the complexities associated with the handling of  lyobeads in PCR applications. The protective plastic pod eases excipient requirements, reducing time for recipe formulations. When dissolving the lyophilized reagents for use, the mesh at the bottom filters air bubbles that could otherwise interfere with detection. This shortens development time as it eliminates the need to build agitation mechanisms to remove air bubbles. By simplifying the lyophilization process and achieving a reliable reagent onboarding process, plastic mesh pods enable faster and more cost-effective product launch and production ramp up of novel PCR devices.

Conclusion

The plastic mesh pod is an innovative solution to the limitations of lyobeads for lyophilizing reagents used in PCR applications. The pod offers efficient handling, scalability in mass production, and improved speed to market, making it an excellent choice for product developers and manufacturers who want to improve PCR device production efficiency and yield.

For more information about plastic mesh pods and how they can benefit your project, contact Enplas today to speak with an engineer about your needs.

 

Microfluidics Flow Automation Guide for the RMVP system

Learn how to easily automate microfluidic flow control with the footprint of a small hand-held device, using Enplas’s RMVP system.

Global Enplas group celebrates 40 years of operation in the U.S.       

Enplas opened its first production site in the U.S. to meet the demand for locally sourced video and audio cassette components.

In 2020, the Enplas Corporation celebrated 40 years of conducting business in the U.S.

The Enplas Corporation is a custom injection molding solutions company based in Japan that today operates in 14 countries.

Enplas (U.S.A.) was the Enplas Corporation’s first production site in the U.S. It was founded in 1980 in Marietta, Ga. Initially, Enplas (U.S.A.) was established to meet the demand for locally sourced video and audio cassette components such as reels and hubs. As demand for plastic cassette components waned in the 1990s, the company applied its core manufacturing technologies to accurately injection mold round shapes to develop precision plastic gears to be used in sensitive applications such as printers and automotive. As the company evolved, it further developed its plastic gear technologies to adapt to the new ways in which users were interacting with their vehicles, such as electric parking brakes, electric seatbelts, power lift gates, and more—all applications that require high levels of strength and quietness.

Meanwhile, Enplas expanded into other industries and regions of the U.S. It now serves customers in industries as diverse as medical, automotive, semiconductor sockets, optics, and consumer products.

Enplas Life Tech is Enplas Corporation’s U.S.-based company providing medical molding services for both development and mass production, including COVID-19 diagnostics and cutting-edge microfluidic devices. The company offers customers dedicated, transparent customer service and engineering expertise to provide high-quality products and services. We are proud that our customers trust Enplas Life Tech as their source for medical molding services.

Read the press release on the Enplas (U.S.A.) website here.

Enplas Life Tech to present, exhibit at the Lab-on-a-Chip & Microfluidics Congress 2019

Presentation titled “Challenges and Solutions for Fluid Sealing Interfaces in Diagnostics Devices”

ASHEVILLE, N.C.—Enplas Life Tech (ELT), a single-source manufacturer based here that mass produces and prototypes complex medical-grade plastic components for the life sciences, will exhibit and present at the Lab-on-a-Chip & Microfluidics World Congress San Diego on October 7-9.

The Lab-on-a-Chip & Microfluidics World Congress San Diego brings together researchers and industry participants from academia and industry to discuss the latest innovations and developments in the lab-on-a-chip and microfluidics fields.

On October 9 at 9:30 AM, Enplas Life Tech Sales Manager, Scot MacGillivray, will present ELT’s experience solving complex challenges with fluid sealing interfaces in diagnostic devices. His presentation will include design best practices for multi-functional devices, chip-to-world interfaces and robust fluid sealing for inlet and outlet ports in cartridge-type diagnostic devices.

“We’re very excited to participate in the Lab-on-a-Chip & Microfluidics Congress 2019 to discuss our engineering and manufacturing experience with potential partners and customers,” said Mr. MacGillivray. “We hope companies use our expertise to help solve fluid sealing issues common in diagnostic device design.”

Enplas Life Tech representatives will be available at booth #11 for inquiries about its engineering and manufacturing services and to answer questions about Mr. MacGillivray’s presentation.

Enplas Life Tech mass produces and prototypes complex, medical-grade plastic components with the level of precision necessary in the life sciences. With more than 20 years of experience, Enplas Life Tech provides one-stop service for design optimization and design for manufacturability, in-house tooling, clean room injection molding and assembly, inspection and evaluation. Its ISO 13485:2016-certified facility is part of Enplas Global, a worldwide network that provides ELT’s customers with seamless global supply of their components. To learn more, visit www.enplaslifetech.com.

Founded in Tokyo, Japan, in 1962, Enplas Corporation has expanded globally into one of the largest independent manufacturers of engineered plastics. Enplas Japan is listed on the first section of the Tokyo Stock Exchange and operates 26 subsidiaries and branch offices in 15 countries. Enplas America is the holding company of all U.S. subsidiaries, including Enplas Microtech, Inc., a company focused on high-technology plastic microfluidics located in the San Francisco Bay area. The group’s name stands for Engineering Plastics.

Oct 7. 2019 Press Release PDF

For more information contact:

Eriko Ota
eriko@enplaslifetech.com

Enplas Life Tech Maintains Customer Service Dedication, Innovation in First Year

Asheville, NC—There’s an anniversary to celebrate: it’s been one year since Enplas, a multinational manufacturer of engineered plastics, rebranded the North Carolina-based PolyLinks as “Enplas Life Tech,” following its acquisition in June 2017.

In the time since, Enplas Life Tech has strengthened its commitment to customers in the life science industry with increased technological capability in manufacturing high-precision consumables.

As Enplas’s flagship east coast life science consumables production center, Enplas Life Tech brings products to customers in new ways. With wider geographical coverage, the global Enplas group achieves faster product delivery with a wider variety of products, augmenting Enplas’s unique microfluidics manufacturing technology with Enplas Life Tech’s expertise in thermoplastic elastomers for fluid sealing.

Both Enplas’s global business and Enplas Life Tech share the same commitment to customers: they are dedicated to solving the most difficult development problems with clients with the highest quality.

The expanded global Enplas group brings many benefits to customers in the life science and biotechnology industry from their expanded network over the U.S.:

  • Easy geographical access from both east and west coasts.
  • Availability of intricate microfluidics and auxiliary products (e.g., cartridge housings, reagent bottle sealings) including systems that require robust thermoplastic elastomer (TPE) air or liquid sealing. This applies to any life science application, from pharmaceutical manufacturing to in-vitro diagnostics (IVD) such as next generation sequencing (NGS), polymerase chain reaction (PCR), immunoassay, electrophoresis, and single cell analysis including sample preparation.
  • Availability of both rapid prototyping and cleanroom mass production and assembly in the U.S.

The Enplas group aims to serve more of the needs of the life science industry to make the world a better place than the day before.

Learn more about Enplas Life Tech’s products and services helping the life science industry with manufacturing precision plastic device and consumables here.

About Enplas Life Tech, Inc.

www.enplaslifetech.com

230 Sardis Road, Asheville, NC 28806, U.S.A.

Enplas Life Tech is a company dedicated to both prototyping and mass producing complex engineered plastics with a level of precision necessary in the life sciences. The company has more than 20 years of experience in the industry, providing a one-stop service from design optimization, in-house tooling, clean room injection molding, clean room assembly, inspection and evaluation with high quality standards. The company provides consumable parts to applications including sample prep, PCR, sequencing, mass spectrometry, electrophoresis, and other pharmaceutical manufacturing processes. The company serves a wide range of customers from startups to market leaders.

About the Enplas Group

http://enplas.co.jp/english/

Enplas Japan: Shin-Marunouchi Center Bldg. 9F, 1-6-2 Marunouchi, Chiyoda-ku, Tokyo 100-0005, Japan

Enplas America: 299 Park Ave, 41st Floor New York, NY 10171, U.S.A.

Founded in Tokyo, Japan, in 1962, Enplas Corporation has expanded globally into one of the largest independent manufacturers of engineered plastics. The Enplas group’s underlying foundation is its diverse, integrated technical capabilities, including ultra-precision mold design, mold manufacturing technologies, molding, and research and development. The group’s diverse product portfolio includes automotive, office automation, semiconductor peripherals, optics, and life science products. Enplas Japan is listed on the first section of the Tokyo Stock Exchange and operates 26 subsidiaries and branch offices in 15 countries. Enplas America is the holding company of all U.S. subsidiaries, including Enplas Microtech, Inc., a company producing high-technology plastic microfluidics located in the San Francisco Bay area. The group’s name stands for Engineering Plastics.

Jan 31. 2019 Press Release PDF

For more information contact:

Eriko Ota, Marketing and Communications Manager
Main: +1-828-633-2250
eriko@enplaslifetech.com

New Name: PolyLinks, Inc. becomes Enplas Life Tech, Inc.

Asheville, NC / New York, NY / Tokyo, Jan 15, 2018 – PolyLinks, Inc., a molder of precision injection components catering to the life science industry, has changed its name to Enplas Life Tech, Inc. Along with the name change, the company has launched a new website www.enplaslifetech.com. These changes are a result of the company’s acquisition by the Enplas group in June 2017. Headquartered in Japan, the Enplas group is one of the largest independent manufacturers of precision engineered plastic components. The holding company of all U.S. subsidiaries, Enplas America, is located in New York, NY.

The name change aims to unify the corporate brand to provide easier identification and more efficient logistical procedures to all customers. The new name emphasizes the company’s solid commitment to serve the life science industry and better reflects the increased technological capabilities in ultra-high precision microfluidics, onboard valve and pump technologies for sample prep, fully automated, endotoxin-free manufacturing and assembly, as well as nano-scale clean room molding, assembly and inspection systems, all gained through the integration with Enplas. Enplas Life Tech aims to bring the values and capabilities of Enplas to its customers.  Enplas Life Tech can now leverage a global supply chain and ensure continuity of supply.  Enplas Life Tech will also be more responsive to its customers, manage market and geopolitical risk better and bring the technical resources of its parent, Enplas, to help its customers to design, develop and deliver the next generation of life science products. The new name and brand will allow the company to expand its already strong international presence by attracting additional new customers specifically interested in Life Science technologies.  The change also signifies Enplas Life Tech’s stronger bond with the Enplas group, and its willingness to serve all customers with global teamwork.

About Enplas Life Tech, Inc.

www.enplaslifetech.com

230 Sardis Road, Asheville, NC 28806, U.S.A.

Enplas Life Tech is a company dedicated to both prototyping and mass producing complex engineered plastics with a level of precision necessary in the life sciences. The company has more than 20 years of experience in the industry, providing a one-stop service from design optimization, in-house tooling, clean room injection molding, clean room assembly, inspection and evaluation with high quality standards. The company provides consumable parts to applications including sample prep, PCR, sequencing, Mass Spectrometry, and Electrophoresis etc, and other pharmaceutical manufacturing processes. The company serves a wide range of customers from start-ups to market leaders.

About the Enplas Group

http://enplas.co.jp/english/

Enplas Japan: Shin-Marunouchi Center Bldg. 9F, 1-6-2 Marunouchi, Chiyoda-ku, Tokyo 100-0005, Japan

Enplas America: 299 Park Ave, 41st Floor New York, NY 10171, U.S.A.

Founded in Tokyo, Japan, in 1962, Enplas Corporation has expanded globally into one of the largest, independent manufacturers of engineered plastics. The Enplas group’s underlying foundation is its diverse, integrated technical capabilities, including ultra-precision mold design, mold manufacturing technologies, molding, and research and development. The group’s diverse product portfolio includes automotive, office automation, semiconductor peripherals, optics, and life science products. Enplas Japan is listed on the first section of the Tokyo Stock Exchange, and operates 26 subsidiaries and branch offices in 15 countries. Enplas America is the holding company of all U.S. subsidiaries, including Enplas Microtech Inc, a company catered to producing high technology plastic microfluidics located in the Bay Area. The group’s name stands for Engineering Plastics.

For more information about this topic, please contact Eriko Ota at eriko@enplaslifetech.com.

Jan. 15, 2018 Press Release PDF

PolyLinks, Inc. becomes group company of Enplas Corp. of Japan

Precision parts producer Enplas Corp. of Japan has acquired injection molder PolyLinks Inc. for an undisclosed price, a combination that stages PolyLinks to be a lead manufacturing resource to the Life Science industry. This collaboration also provides Enplas with an established foothold in North America from which to expand its medical and biotech
business segment.

Asheville, N.C.-based PolyLinks is an injection molding and assembly manufacturer serving the biotech and medical industries. The firm operates a 45,000-square-foot facility with three cleanrooms. PolyLinks also builds its own tooling in-house.

Enplas made the purchase through its Enplas America Inc. unit. The firm operates in 15 countries and has annual sales of $400 million. Enplas provides mold building, high precision plastics manufacturing and research and development to the automotive, semiconductor, optical device, and biotechnology industries. Enplas already operates an injection molding plant in Marietta, Ga., which provides ultra-high precision gears to automotive, office automation, and other industries.

Together, Enplas and PolyLinks are excited to better serve the life science industry with their joined and expanded capabilities.